Clinical Trial

Optimizing Brain Excitability in Depression

Name: Optimizing Brain Excitability in Depression — clinical trial record (NCT07242105)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TARGET

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this study is to improve depression treatment by establishing reliable prefrontal excitability markers through Targeting with Automated Real-time Guidance for Enhancing TEPs (TARGET).

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-11-19; most recent amendment 2026-02-06.

Trial Details

NCT Number	NCT07242105
Lead Sponsor	Stanford University Collaborators: National Institute of Mental Health (NIMH)
Conditions	Major Depressive Disorder
Enrollment	145 participants
Start Date	2025-10-23
Primary Completion	2029-08-30 (estimated)
Study Completion	2029-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-10